Letter to the Editor: Atezolizumab plus Bevacizumab for Hepatocellular Carcinoma in the Real World. Zhang JW, Fang J, Xun Z, Xu Y, et al. Hepatology 2022 May 23. doi: 10.1002/hep.32588.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Zhang JW, Fang J, Xun Z, Xu Y, et al. Letter to the Editor: Atezolizumab plus Bevacizumab for Hepatocellular Carcinoma in the Real World. Hepatology 2022 May 23. doi: 10.1002/hep.32588.
PMID: 35604038